David Veitch
Vorstandsvorsitzender bei BASILEA PHARMACEUTICA AG
Vermögen: 55 989 $ am 30.04.2024
Aktive Positionen von David Veitch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Vorstandsvorsitzender | 19.04.2018 | - |
| Corporate Officer/Principal | 01.09.2014 | 19.04.2018 |
Karriereverlauf von David Veitch
Ehemalige bekannte Positionen von David Veitch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.01.2012 | 01.01.2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01.01.2004 | 01.01.2011 |
Ausbildung von David Veitch
| University of Bristol | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
- Börse
- Insiders
- David Veitch
- Erfahrung
